Evaluating the role of recombinant erythropoietin in nephrogenic systemic fibrosis - 19/08/11
Funding sources: None. |
|
Conflicts of interest: None declared. |
|
Presented in part at the Western Regional Epidemiology Network Conference, Ashland, Oregon, May 17-19, 2001, and the International Epidemiology Association Conference, Cusco, Peru, September 2-6, 2001. Limited preliminary findings from this investigation were published as a public health dispatch (MMWR Morb Mortal Wkly Rep 2002;51:25-6). |
|
This public health investigation was submitted to the Science Office in the Office of Workforce and Career Development (OWCD), Centers for Disease Control and Prevention, for research/nonresearch determination. The OWCD Science Office determined that the activities involved in the investigation constituted an urgent public health response and did not require submission of a protocol to the institutional review board. |
|
Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. |
Vol 57 - N° 4
P. 725-727 - octobre 2007 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?